curex semaglutide FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly Compounded GLP-1 Medication

The discourse at Vitafoods made it evident that the path forwards will require diligent research, robust clinical data and clear communication to consumers about the benefits and limitations of nutraceutical solutions in this rapidly evolving landscape

Nick Conway, president of Rx solutions at NFP, a New York City-based global benefits consultant and insurance brokerage firm, agreed

GLP-1 therapy is a proven tool for weight management and metabolic health, but side effects can interfere with consistency

Then they notice something strange

Study type: clinical review

A better understanding of both GLP-1 and LFD as well as their connection has important therapeutic implications